Connection

Michael Hallek to Clinical Trials, Phase II as Topic

Back to Details
This is a "connection" page, showing publications Michael Hallek has written about Clinical Trials, Phase II as Topic.
Michael Hallek
Connection Strength
0.069
Clinical Trials, Phase II as Topic
  1. Comprehensive Safety Analysis of Venetoclax Monotherapy for Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia. Clin Cancer Res. 2018 09 15; 24(18):4371-4379.
    View in: PubMed
    Score: 0.035
  2. Impact of gender on outcome after chemoimmunotherapy in patients with chronic lymphocytic leukemia: a meta-analysis by the German CLL study group. Leukemia. 2017 10; 31(10):2251-2253.
    View in: PubMed
    Score: 0.033
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.